AI-powered personalized exercise coaching for women with breast cancer
Official title: Effect of an Artificial Intelligence-Based Personalized Exercise Coaching System on Exercise Adherence and Quality of Life in Patients With Breast Cancer: A Randomized Controlled Trial
Run by Shanghai Jiao Tong University School of Medicine · NCT07844941 · Data updated 2026-11-12
This trial tests whether an AI-driven, personalized exercise program helps women with breast cancer after treatment compared to standard exercise guidance.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | Shanghai Jiao Tong University School of Medicine Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | July 22, 2026 |
| Main results expected | March 22, 2027 |
| Study ends | March 22, 2027 |
| Registry record updated | September 28, 2026 |
| Trial ID | NCT07844941 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18-70 with pathologically confirmed breast cancer who have completed major treatment, are clinically stable, and have no major cardiopulmonary contraindications.
✕Probably not a fit
Patients with unstable disease, significant cardiopulmonary limitations, or conditions preventing ongoing physical activity may not benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-center, open-label randomized trial enrolling 100 female breast cancer survivors who have completed treatment and are clinically stable. Participants are randomized 1:1 to receive either an AI-based personalized exercise coaching system or conventional exercise guidance from healthcare professionals, with the program lasting 6 months. The AI system uses wearable data to tailor and adjust exercise recommendations in real time, while adherence and several secondary outcomes are monitored at baseline, 3 months, and 6 months. Primary outcome is exercise adherence; secondary outcomes include quality of life, psychological status, and physical function. Regular assessments will compare the AI-guided approach to standard guidance to determine potential benefits and safety.
Why it matters
Potential benefit: If successful, the AI-guided program could improve personalized support and adherence to exercise, potentially boosting quality of life and physical function for breast cancer survivors.
How similar studies have gone: Previous studies suggest that personalized, digitally supported exercise can improve adherence and outcomes, but AI-driven coaching in this population is relatively novel and exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Provision of written and dated informed consent. 2. Female participants aged 18 to 70 years. 3. Pathologically confirmed breast malignancy. 4. Completion of major cancer treatment, including surgery, chemotherapy, and/or radiotherapy, with clinically stable disease. 5. No severe cardiopulmonary dysfunction or contraindications to exercise. Exclusion Criteria: 1. Have not undergone breast cancer surgery. 2. Mental or psychological condition, as judged by the investigator, that would prevent adherence to the intervention or completion of follow-up.
Where it's running
-
Ruijin Hospital
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Siji Zhu, MD
- Email: zsj_mu@yeah.net
- Phone: 021-64370045
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.